WEDNESDAY, July 28, 2021 (HealthDay News) — An outside advisor to the U.S. Food and Drug Administration’s review of the controversial Alzheimer’s drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable collaboration between regulators and the drug’s maker. “I’m not surprisedContinue Reading

Here’s some of HealthDay’s top stories for Wednesday, July 28: FDA advisor who panned new Alzheimer’s drug speaks out. Dr. G. Caleb Alexander was one of 10 advisors on an 11-member FDA panel who voted against approval of the controversial new Alzheimer’s drug, Aduhelm. The agency approved the drug anyway.Continue Reading

WEDNESDAY, July 28, 2021 (HealthDay News) — The U.S. Department of Defense isn’t doing enough to guard service members against exposure to so-called “forever chemicals” associated with a range of health problems, the department’s inspector general said Tuesday. The internal audit also noted that the department is falling short onContinue Reading

WEDNESDAY, July 28, 2021 (HealthDay News) — Republicans who say they won’t get the COVID-19 vaccine are more likely to reconsider their stance if high-profile Republicans urge them to take the jab, a new study finds. Similar vaccination pleas from Democratic sources may actually harden their resistance, researchers found. UnvaccinatedContinue Reading